AusHealth’s partnership with Ventora Medical will advance an innovative device that promises to improve breathing support for newborns Each year in Australia, 30,000 newborns will need some form of respiratory support. This includes 10,000 premature babies whose lungs are not fully developed. Existing neonatal respiratory support methods – such as Continuous Positive Airway Pressure (CPAP) […]

Belinda Wade is the new manager of AusHealth Ventures, the division responsible for funding and administering more than a dozen medical research projects. She started her career as a medical researcher, before moving into roles more focussed on the commercialisation of scientific innovation; she became Business Development Coordinator at Flinders University and more recently, General

ABC interview explores groundbreaking South Australian discovery in the fight against septic shock University of Adelaide’s Professor David Torpy and AusHealth CEO Dr Justin Coombs joined Rory McClaren on ABC Radio Adelaide to share exciting progress from the Adelaide research team. They discussed how a naturally occurring blood protein — corticosteroid-binding globulin (CBG) — could

Team identifies the first natural anti-inflammatory agent since cortisone was found in the 1940s In a world-first, an Adelaide team has discovered a naturally occurring blood protein – a type of corticosteroid-binding globulin (CBG) – that could significantly decrease mortality caused by septic shock. The CBG project is a collaboration between the University of Adelaide,

AusHealth is supporting the development of a drug-testing technology that’s more efficient, more usable and more ethical Australian start-up OminiWell has developed a drug-screening ‘chip’ to make it easier to test an individual patient’s cancer cells for treatment. The device will also render research labs less reliant on animal testing. OminiWell’s BioTwin Chip is not

PhD students invited to apply for five $10,000 prizes to be spent on ‘literally, anything they like!’

AusHealth’s collaboration with Epidermolysis Bullosa (EB) Research Partnership Australia is advancing the use of phage therapy to treat children with life-threatening genetic disorders. Epidermolysis Bullosa is the umbrella term for a group of rare genetic disorders that attack the body’s largest organ – the skin. This painful disorder causes layers of skin (including layers around

Dr Tina Lavranos manages a multi-million-dollar portfolio of research projects being funded by medical research charity, AusHealth. Tina knows how hard it is to pitch for money — in the 1990s, she was a young post-doc seeking funding from the federal government. Now she’s on the other side of the table, and it’s her job